Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-21-084279
Date:2021-06-21
Issuer: INTERCEPT PHARMACEUTICALS, INC. (ICPT)
Original Submission Date:

Reporting Person:

SAIK ANDREW
C/O INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, FLOOR 37 NEW YORK, NY 10001

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-21 A 52,156 a $0.00 52,156 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
OPTION TO PURCHASE COMMON STOCK 20.84 2021-06-21 deemed execution date A 72,540 (a) 2031-06-21 common stock 72,540 $20.84 72,540 direct
Footnotes
IDfootnote
f1 represents restricted stock units granted to the reporting person. each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. 1/4th of the shares subject to the award will vest on the first anniversary of the vesting commencement date, and the remaining shares will vest in equal quarterly installments in arrears over the three-year period commencing on the first anniversary of the vesting commencement date and ending on the fourth anniversary of the vesting commencement date. the vesting commencement date is june 21, 2021.
f2 1/4th of the options subject to the award will vest and become exercisable on the first anniversary of the vesting commencement date, and the remaining options will vest and become exercisable in equal monthly installments in arrears over the three-year period commencing on the first anniversary of the vesting commencement date and ending on the fourth anniversary of the vesting commencement date. the vesting commencement date is june 21, 2021.

Elevate your investments